Russell Investments Group
KURA icon

Russell Investments Group’s Kura Oncology KURA Stock Holding History

Russell Investments Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
113,083
+29,550
+35% +$279K ﹤0.01% 2352
2026
Q1 		$679K Sell
83,533
-76,498
-48% -$657K ﹤0.01% 2391
2025
Q4 		$1.66M Sell
160,031
-167,939
-51% -$1.76M ﹤0.01% 1975
2025
Q3 		$2.9M Sell
327,970
-8,522
-3% -$60.7K ﹤0.01% 1650
2025
Q2 		$1.94M Sell
336,492
-2,367
-0.7% -$14.5K ﹤0.01% 1730
2025
Q1 		$2.24M Buy
338,859
+40,197
+13% +$313K ﹤0.01% 1631
2024
Q4 		$2.6M Buy
298,662
+45,892
+18% +$660K ﹤0.01% 1531
2024
Q3 		$4.94M Buy
252,770
+34,328
+16% +$696K 0.01% 1191
2024
Q2 		$4.5M Sell
218,442
-5,854
-3% -$120K 0.01% 1199
2024
Q1 		$4.78M Sell
224,296
-488
-0.2% -$9.49K 0.01% 1191
2023
Q4 		$3.23M Buy
224,784
+28,817
+15% +$283K 0.01% 1353
2023
Q3 		$1.79M Buy
195,967
+53,462
+38% +$543K ﹤0.01% 1615
2023
Q2 		$1.51M Buy
142,505
+55,539
+64% +$657K ﹤0.01% 1720
2023
Q1 		$1.06M Sell
86,966
-19,151
-18% -$239K ﹤0.01% 1932
2022
Q4 		$1.32M Sell
106,117
-15,325
-13% -$223K ﹤0.01% 1834
2022
Q3 		$1.66M Hold
121,442
– – ﹤0.01% 1651
2022
Q2 		$2.22M Buy
121,442
+36,444
+43% +$524K ﹤0.01% 1526
2022
Q1 		$1.36M Buy
84,998
+27,102
+47% +$391K ﹤0.01% 1815
2021
Q4 		$810K Buy
57,896
+7,165
+14% +$116K ﹤0.01% 2257
2021
Q3 		$949K Buy
50,731
+12,788
+34% +$241K ﹤0.01% 2211
2021
Q2 		$790K Buy
37,943
+5,927
+19% +$147K ﹤0.01% 2419
2021
Q1 		$904K Hold
32,016
– – ﹤0.01% 2294
2020
Q4 		$1.04M Buy
+32,016
New +$1.13M ﹤0.01% 2094
2020
Q1 		– Sell
-7,538
Closed -$103K – 3092
2019
Q4 		$103K Hold
7,538
– – ﹤0.01% 2878
2019
Q3 		$114K Buy
+7,538
New +$134K ﹤0.01% 2796

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Russell Investments Group's KURA Position: Q2 2026 in Review

Russell Investments Group increased its Kura Oncology (KURA) stake by 35% in Q2 2026, buying an estimated $279K and bringing the position to 113,083 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2352.

Russell Investments Group first reported a position in KURA in Q3 2019 and has held it in 25 quarters since. The position peaked at $4.94M in Q3 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Russell Investments Group held 113,083 shares of Kura Oncology worth $1.24M as of Q2 2026.
  • Russell Investments Group bought 29,550 Kura Oncology shares in Q2 2026, an estimated $279K.
  • Kura Oncology made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2352 holding.
  • Russell Investments Group first reported a position in Kura Oncology in Q3 2019 and has held it in 25 quarters since.
  • Russell Investments Group's Kura Oncology position peaked at $4.94M in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.